James C. Foster, Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 28,733 shares at $275.00 ($7.9M) on 2026-08-10, disclosed to the SEC on 2026-08-11.
Scheduled sale ($7.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRL | BUY | 2025-02-21 | $2.0M | — | Filing → |
| CRL | SELL | 2024-08-05 | $6.3M | — | Filing → |
| CRL | BUY | 2023-11-15 | $2.0M | — | Filing → |